Medscape |
---|
FDA OKs Low-Dose Colchicine for Broad CV Indication |
![]() The US Food and Drug Administration has approved the anti-inflammatory drug colchicine 0.5 mg tablets (Lodoco) as the first specific anti-inflammatory drug demonstrated to reduce the risk for myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease. |
||
2023-06-20 Read more about this article in source |
-
The ‘Six Pillars of Brain Health’ offers a game plan to maintain cognitive function 04/25/2025
-
Avocados, cheese and nuts are high in calories but have big health benefits 04/25/2025
-
Perfecting the squat before trying a lunge can start you off on the right foot 04/25/2025